Literature DB >> 29268949

Atezolizumab for platinum-treated metastatic urothelial carcinoma.

Francesco Massari1, Vincenzo Di Nunno2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29268949     DOI： 10.1016/S0140-6736(17)33298-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  The TGF-β/Smad Pathway Inhibitor SB431542 Enhances The Antitumor Effect Of Radiofrequency Ablation On Bladder Cancer Cells.

Authors:  Hong-Qing Zhou; Ming-Sheng Liu; Ti-Bin Deng; Ping-Bo Xie; Wei Wang; Tao Shao; Yao Wu; Peng Zhang
Journal:  Onco Targets Ther       Date:  2019-09-23       Impact factor: 4.147

Review 2.  Key Role of Obesity in Genitourinary Tumors with Emphasis on Urothelial and Prostate Cancers.

Authors:  Matteo Santoni; Alessia Cimadamore; Francesco Massari; Francesco Piva; Gaetano Aurilio; Angelo Martignetti; Marina Scarpelli; Vincenzo Di Nunno; Lidia Gatto; Nicola Battelli; Liang Cheng; Antonio Lopez-Beltran; Rodolfo Montironi
Journal:  Cancers (Basel)       Date:  2019-08-22       Impact factor: 6.639

3.  The effectiveness of chemotherapy for patients with pT3N0M0 renal pelvic urothelial carcinomas: An inverse probability of treatment weighting comparison using Surveillance, Epidemiology, and End Results data.

Authors:  Zefu Liu; Jialing Huang; Xiangdong Li; Chaowen Huang; Yunlin Ye; Jinxin Zhang; Zhouwei Liu
Journal:  Cancer Med       Date:  2020-06-25       Impact factor: 4.452

4.  Dysregulation of the Immune Microenvironment Contributes to Malignant Progression and Has Prognostic Value in Bladder Cancer.

Authors:  Zongtai Zheng; Shiyu Mao; Wentao Zhang; Ji Liu; Cheng Li; Ruiliang Wang; Xudong Yao
Journal:  Front Oncol       Date:  2020-12-16       Impact factor: 6.244

Review 5.  Pretreatment clinical and hematologic prognostic factors of metastatic urothelial carcinoma treated with pembrolizumab: a systematic review and meta-analysis.

Authors:  Takafumi Yanagisawa; Keiichiro Mori; Satoshi Katayama; Hadi Mostafaei; Fahad Quhal; Ekaterina Laukhtina; Pawel Rajwa; Reza Sari Motlagh; Abdulmajeed Aydh; Frederik König; Nico C Grossmann; Benjamin Pradere; Jun Miki; Takahiro Kimura; Shin Egawa; Shahrokh F Shariat
Journal:  Int J Clin Oncol       Date:  2021-11-10       Impact factor: 3.402

6.  Generation of triacyl lipopeptide-modified glycoproteins by metabolic glycoengineering as the neoantigen to boost anti-tumor immune response.

Authors:  Yujia Zhao; Siyu Li; Jianying Lv; Yonghui Liu; Yanan Chen; Yanhua Liu; Xiaosu Chen; Jia Li; Xuan Qin; Xiaoshuang Wang; Jie Shi; Yi Shi; Rong Xiang
Journal:  Theranostics       Date:  2021-05-25       Impact factor: 11.556
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.